Clinical trials
Phase 1 Mental Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 5 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Luye Pharma Group Ltd. | 5 |
| Yale University | 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 |
| GlaxoSmithKline | 2 |
| National Institute on Drug Abuse (NIDA) | 2 |
| Oregon Research Institute | 2 |
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Brown University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Disorders | 40 |
| Mood Disorders | 8 |
| Schizophrenia | 8 |
| Substance-Related Disorders | 7 |
| Major Depressive Disorder | 6 |
| Brain Diseases | 5 |
| Depressive Disorder | 5 |
| Anxiety Disorders | 4 |
| Central Nervous System Diseases | 4 |
| Dementia | 4 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.